ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
- Public sites
- 54
- Start date
- Jun 20, 2022
Hillcrest Medical Center is home to the Oklahoma Heart Institute’s structural heart program, providing heart valve repair and replacement, including TAVR and other surgical and nonsurgical transcatheter valve therapies. Care is provided by a multidisciplinary team of interventional cardiologists, cardiothoracic surgeons, cardiovascular imaging specialists, and other providers, with minimally invasive options available for eligible patients.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
The ENCIRCLE Trial
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Tulsa, OK
Tulsa, OK
Oklahoma City, OK